EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of a Small Molecule with an Inhibitory Role for RAB11

Camille Lempicki iD, Julian Milosavljevic iD, Christian Laggner, Simone Tealdi, Charlotte Meyer iD, Gerd Walz, Konrad Lang iD, Carlo Cosimo Campa, Tobias Hermle iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Camille Lempicki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany. Hauptthemen laut MEDLINE: rab GTP-Binding Proteins, Autophagy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Atomwise AIMS Award, Medical Faculty of the University of Freiburg (MO-TI-VATE Fellowship).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RAB11, a pivotal RabGTPase, regulates essential cellular processes such as endocytic recycling, exocytosis, and autophagy. The protein was implicated in various human diseases, including cancer, neurodegenerative disorders, viral infections, and podocytopathies. However, a small-molecular inhibitor is lacking. The complexity and workload associated with potential assays make conducting large-scale screening for RAB11 challenging. We employed a tiered approach for drug discovery, utilizing deep learning-based computational screening to preselect compounds targeting a specific pocket of RAB11 protein with experimental validation by an in vitro platform reflecting RAB11 activity through the exocytosis of GFP. Further validation included the exposure of Drosophila by drug feeding. In silico pre-screening identified 94 candidates, of which 9 were confirmed using our in vitro platform for Rab11 activity. Focusing on compounds with high potency, we assessed autophagy, which independently requires RAB11, and validated three of these compounds. We further analyzed the dose–response relationship, observing a biphasic, potentially hormetic effect. Two candidate compounds specifically caused a shift in Rab11 vesicles to the cell periphery, without significant impact on Rab5 or Rab7. Drosophila larvae exposed to another candidate compound with predicted oral bioavailability exhibited minimal toxicity, subcellular dispersal of endogenous Rab11, and a decrease in RAB11-dependent nephrocyte function, further supporting an inhibitory role. Taken together, the combination of computational screening and experimental validation allowed the identification of small molecules that modify the function of Rab11. This discovery may further open avenues for treating RAB11-associated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rab GTP-Binding ProteinsAutophagyAnimalsHumansDrug DiscoveryDrosophila ProteinsDrosophilaSmall Molecule LibrariesDrosophila melanogasterExocytosisLarvarab11 GTP-Binding Proteins

Stichwörter der Autor:innen

Drosophila nephrocytesRab11drug discoveryendocytosishigh-throughput screeningmachine learningvirtual screening

Substanzen

rab GTP-Binding ProteinsDrosophila ProteinsSmall Molecule Librariesrab11 GTP-Binding Proteins

Autor:innen und Institutionen

  • Renal Division, Department of Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany.
  • Atomwise Inc., 250 Sutter St #650, San Francisco, CA 94108, USA.
  • Italian Institute for Genomic Medicine, Str. Prov. le 142, km 3.95, 10060 Candiolo, Turin, Italy.
  • Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Turin, Italy.
  • CIBSS-Centre for Integrative Biological Signalling Studies, 79104 Freiburg, Germany.
  • Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy.

ORCID-Profile: Camille Lempicki, Julian Milosavljevic, Charlotte Meyer, Konrad Lang, Tobias Hermle

Förderung

  • Deutsche Forschungsgemeinschaft
  • Atomwise AIMS Award
  • Medical Faculty of the University of Freiburg (MO-TI-VATE Fellowship)
  • the IIGM internal grant program, CARIPLO-Telethon grant
  • AIRC
  • Berta-Ottenstein-Program of the Faculty of Medicine, University of Freiburg
  • Heisenberg Program of the DFG

Zitieren

APA

Lempicki, C., Milosavljevic, J., Laggner, C., Tealdi, S., Meyer, C., Walz, G., Lang, K., Campa, C. C., & Hermle, T. (2024). Discovery of a Small Molecule with an Inhibitory Role for RAB11. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313224

Vancouver

Lempicki C, Milosavljevic J, Laggner C, Tealdi S, Meyer C, Walz G, et al. Discovery of a Small Molecule with an Inhibitory Role for RAB11. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313224

BibTeX
@article{Lempicki2024,
  author = {Lempicki, Camille and Milosavljevic, Julian and Laggner, Christian and Tealdi, Simone and Meyer, Charlotte and Walz, Gerd and Lang, Konrad and Campa, Carlo Cosimo and Hermle, Tobias},
  title = {Discovery of a Small Molecule with an Inhibitory Role for RAB11},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313224}
}
Kostenlos starten →